|1.||Fuchs, Robert: 1 article (10/2009)|
|2.||Leitinger, Gerd: 1 article (10/2009)|
|3.||Schauenstein, Konrad: 1 article (10/2009)|
|4.||Sadjak, Anton: 1 article (10/2009)|
|5.||Stelzer, Ingeborg: 1 article (10/2009)|
|6.||Haas, Helga S: 1 article (10/2009)|
|7.||Grahn, Ruth E: 1 article (08/2002)|
|8.||Maier, S F: 1 article (08/2002)|
|9.||Sparks, P D: 1 article (08/2002)|
|10.||Hammack, S E: 1 article (08/2002)|
04/01/1991 - "Microinjection of 10.0 nmol benoxathian into the PVN completely reversed the anorexia induced by 2.5, 5.0 or 10.0 mg/kg PPA (IP), yet did not alter the hypodipsia produced by PPA. "
07/01/1993 - "Unlike prior results using the alpha 1-antagonist benoxathian, PVN microinjection of the alpha 2-antagonist rauwolscine in Experiment 3 of the present study failed to block systemically induced PPA anorexia. "
04/01/1991 - "Reversal of phenylpropanolamine anorexia in rats by the alpha-1 receptor antagonist benoxathian."
08/21/2002 - "The enhancement of conditioned fear produced by prior inescapable shock was attenuated by benoxathian administered before inescapable shock or before behavioral testing. "
08/21/2002 - "Benoxathian prevented the impairment of escape responding produced by inescapable shock, but did not reverse this effect when given before testing. "
08/21/2002 - "The selective alpha1 adrenoreceptor antagonist benoxathian was injected into the DRN before exposure to inescapable tail shock or before behavioral testing conducted 24 h later. "
|4.||Acute Erythroblastic Leukemia (Erythroleukemia)
10/01/2009 - "The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells."
10/01/2009 - "Even though the expression of differentiation markers was similar after benoxathian and prazosin treatment in both cell lines, endomitosis of erythroleukemia cells was observed only after prazosin treatment. "
|4.||(2- (2',6'- dimethoxy)phenoxyethylamino)methylbenzo- 1,4- dioxane